| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Microbiology, Mie University School of Medicine, 2-174, Edobashi, Tsu, Mie-ken 514, Japan
We have isolated new MAbs directed against the human fusion regulatory protein 1 (FRP-1; CD98) molecule using human FRP-1-expressing L929 cells as antigens. The biological activities, and in particular the human immunodeficiency virus (HIV)-mediated fusion regulatory activity of seven anti-FRP-1/CD98 MAbs were analysed using the U937/gp160 cell line, which is a CD4+ U937 cell line expressing HIV gp160. Two MAbs induced multi-nucleated giant cell formation in U937/gp160 cells and the other five MAbs showed no fusion-inducing ability. However, four of these MAbs suppressed multinucleated giant cell formation of U937/gp160 cells induced by the activating anti-FRP-1 MAbs. Interestingly, five of the MAbs induced multi-nucleated giant cells in peripheral blood monocytes and one MAb showing fusion-inducing ability in U937/gp160 cells suppressed multinucleated giant cell formation of monocytes induced by anti-FRP-1 MAbs. Furthermore, four of the anti-FRP-1 MAbs suppressed cell fusion of Jurkat/gp160 cells, which are Jurkat cells expressing HIV gp160. Thus, FRP-1/CD98 is capable of either activating or inhibiting HIV-mediated cell fusion depending on whether an enhancing or inhibiting antibody is used, indicating that FRP-1/CD98 is a multipotential molecule. Thus, HIV-mediated cell fusion can be regulated by modification of the FRP-1 system. Furthermore, the present study demonstrates that the FRP-1 and FRP-2 systems are interdependent.
Received 27 March 1996;
accepted 8 July 1996.
This article has been cited by other articles:
|
|
 |
|
  S. Cai, N. Bulus, P. M. Fonseca-Siesser, D. Chen, S. K. Hanks, A. Pozzi, and R. Zent CD98 modulates integrin {beta}1 function in polarized epithelial cells J. Cell Sci., March 1, 2005; 118(5): 889 - 899. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Y. Cho, D. A. Fox, V. Horejsi, K. Sagawa, K. M. Skubitz, D. R. Katz, and B. Chain The functional interactions between CD98, {beta}1-integrins, and CD147 in the induction of U937 homotypic aggregation Blood, July 15, 2001; 98(2): 374 - 382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. E. Woodhead, T. J. Stonehouse, M. H. Binks, K. Speidel, D. A. Fox, A. Gaya, D. Hardie, A. J. Henniker, V. Horejsi, K. Sagawa, et al. Novel molecular mechanisms of dendritic cell-induced T cell activation Int. Immunol., July 1, 2000; 12(7): 1051 - 1061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Zent, C. A. Fenczik, D. A. Calderwood, S. Liu, M. Dellos, and M. H. Ginsberg Class- and Splice Variant-specific Association of CD98 with Integrin beta Cytoplasmic Domains J. Biol. Chem., February 18, 2000; 275(7): 5059 - 5064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Daenke and S Booth HTLV-1-induced cell fusion is limited at two distinct steps in the fusion pathway after receptor binding J. Cell Sci., January 1, 2000; 113(1): 37 - 44. [Abstract] [PDF]
|
|
|
|
|
|
B. A. Mannion, T. V. Kolesnikova, S. H. Lin, S. Wang, N. L. Thompson, and M. E. Hemler The Light Chain of CD98 Is Identified as E16/TA1 Protein J. Biol. Chem., December 11, 1998; 273(50): 33127 - 33129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. PALACIN, R. ESTEVEZ, J. BERTRAN, and A. ZORZANO Molecular Biology of Mammalian Plasma Membrane Amino Acid Transporters Physiol Rev, October 1, 1998; 78(4): 969 - 1054. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
